  The Bio Affinity Company BAC BV (Naarden, the  Netherlands, 

) has entered into an  agreement with Sanofi Pasteur (Lyon, France, 

), the vaccines  arm of the Sanofi-Aventis Group, for the use of BAC’s CaptureSelect customized  affinity ligands for process-scale purification of some of its vaccine  products. Manufactured using a proprietary yeast-based expression system, that  is completely animal-free, CaptureSelect ligands exploit the nature of Camelid  single chain antibody fragments and are designed to provide enhanced stability  and broad antigen-specific binding. 
   


News

The Bio Affinity Company BAC BV (Naarden, the Netherlands, www.bac.nl) has entered into an agreement with Sanofi Pasteur (Lyon, France, www.sanofipasteur.com), the vaccines arm of the Sanofi-Aventis Group, for the use of BAC's CaptureSelect customized affinity ligands for process-scale purification of some of its vaccine products.